AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. We're proud to have a unique workplace culture that inspires innovation and collaboration. We believe in the potential of our people and you’ll develop beyond what you thought possible.
The new R&D Oncology organisation brings together early and late oncology teams, from discovery through to late-stage development, with oncology specific Regulatory and Biometrics groups.
This is an opportunity for a talented and self-motivated scientist to undertake biophysical and structural studies of macromolecular complexes between BRCA2 and other tumour suppressor proteins. You’ll have access to state-of-the-art cryoEM and biophysics infrastructure with a leading structure and biophysics group and work in close collaboration with Prof Ashok Venkitaraman’s group at the MRC Cancer Unit.
For more information and to apply, click here.
